Neuroimaging markers of clinical progression in chronic inflammatory demyelinating polyradiculoneuropathy.

Kalliopi PitarokoiliDietrich SturmAdnan LabediTineke GreinerLynn EitnerNina KumowskiElena K Enax-KrumovaAnna Lena FisseChristoph MaierRalf GoldMartin TegenthoffTobias Schmidt-WilckeMin-Suk Yoon

Published in: Therapeutic advances in neurological disorders (2019)

BUS and corneal total cell infiltration seem to represent early markers for clinical progression in CIDP, thus having the potential to identify at-risk patients and impact treatment decisions.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
single cell
cell therapy
patient reported outcomes
optical coherence tomography
mesenchymal stem cells
risk assessment
combination therapy
patient reported
drug induced
smoking cessation